MADISON, N.J., March 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the
Barclays Capital Healthcare Conference in Miami on Tuesday, March 10, 2009.
The Quest Diagnostics presentation is scheduled to begin at 9:00 a.m. Eastern
Time.
During the conference, the company will reaffirm its 2009 guidance for
revenue growth of approximately 3%, operating income to approach 18% of
revenues, and earnings per diluted share from continuing operations of between
$3.50 and $3.70.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://cc.talkpoint.com/barc002/030909a_rb/?entity=104_3J1C75N and to the
public on www.QuestDiagnostics.com/investor. In addition, the archived
webcast will be available within 24 hours after the conclusion of the live
event and will remain available until April 10, 2009.
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its network of laboratories and patient service
centers, and provides interpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care. Additional company information is available at
www.questdiagnostics.com.
The statements in this press release which are not historical facts may be
forward-looking statements. Readers are cautioned not to place undue reliance
on forward-looking statements, which speak only as of the date that they are
made and which reflect management's current estimates, projections,
expectations or beliefs and which involve risks and uncertainties that could
cause actual results and outcomes to be materially different. Risks and
uncertainties that may affect the future results of the company include, but
are not limited to, adverse results from pending or future government
investigations, lawsuits or private actions, the competitive environment,
changes in government regulations, changing relationships with customers,
payers, suppliers and strategic partners and other factors discussed in
"Business" in Part I, Item 1, "Risk Factors" and "Cautionary Factors that May
Affect Future Results" in Part I, Item 1A, "Legal Proceedings" in Part I,
Item 3, "Management's Discussion and Analysis of Financial Condition and
Results of Operations" in Part II, Item 7 and "Quantitative and Qualitative
Disclosures About Market Risk" in Part II, Item 7A in the company's 2008
Annual Report on Form 10-K and other items throughout the Form 10-K and
Current Reports on Form 8-K.
SOURCE Quest Diagnostics
CONTACT: Laure Park (Investors), +1-973-520-2900, or Wendy Bost,
(Media), +1-973-520-2800